Merck
Worldwide
   

 

Be a Part of a Study

Thank you for your interest in this investigational clinical research study of a drug approved for the treatment of HIV.

ENROLLMENT IN THIS STUDY IS CLOSED.

This study has been registered on www.ClinicalTrials.gov under identifier NCT00764946.

REALMRK
More About

Interactive Map
 
You may be eligible for the study if you are:
  • HIV positive and 16 years of age or older.
Participation in this one-year study includes at no cost:
  • Study-related doctor visits
  • Investigational study drug
  • Laboratory testing
  • In many cases, reimbursement for transportation and childcare may be available.
PrintPrintable Version

Copyright © 2005-2007 Merck & Co., Inc., All rights reserved.

Contact Merck Privacy Policy Terms of Use Copyright Merck & CO., Inc. (USA)